---
title: "GRIPM: Net profit in the first half of 2025 increased by 21.68% year-on-year"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/254771212.md"
description: "GRIPM announced that in the first half of 2025, operating revenue reached 1.79 billion yuan, a year-on-year increase of 18.29%. Net profit was 35.76 million yuan, a year-on-year increase of 21.68%. Basic earnings per share were 0.34 yuan/share, a year-on-year increase of 21.43%"
datetime: "2025-08-27T09:18:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/254771212.md)
  - [en](https://longbridge.com/en/news/254771212.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/254771212.md)
generator: "portal-rs"
---

# GRIPM: Net profit in the first half of 2025 increased by 21.68% year-on-year

GRIPM announced that in the first half of 2025, operating revenue reached 1.79 billion yuan, a year-on-year increase of 18.29%. Net profit was 35.76 million yuan, a year-on-year increase of 21.68%. Basic earnings per share were 0.34 yuan/share, a year-on-year increase of 21.43%

### Related Stocks

- [688456.CN](https://longbridge.com/en/quote/688456.CN.md)

## Related News & Research

- [METALS-Copper hovers below record high as non-US supply tightness remains in focus](https://longbridge.com/en/news/298394789.md)
- [Chenavari white paper flags plastics as 44% of packaging emissions in decarbonization push](https://longbridge.com/en/news/298396573.md)
- [EIQ: FDA setback delays heart failure solution, but strong finances and U.S. growth continue](https://longbridge.com/en/news/298376891.md)
- [Rezubio doses first cohort in Phase I trial of inhaled RZ-520](https://longbridge.com/en/news/298299102.md)
- [Calviks revises Q2 organic growth to 5.66% from 2.84%](https://longbridge.com/en/news/298204820.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**